Related Experiment Video
Updated: Aug 17, 2025

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
A Unique High-Output Cardiac Hypertrophy Phenotype Arising From Low Systemic Vascular Resistance in Cantu Syndrome
Gautam K Singh1,2, Conor McClenaghan2,3, Manish Aggarwal1
1Division of Cardiology, Department of Pediatrics Washington University School of Medicine St. Louis MO.
Insights
Cantu syndrome (CS) causes high-output cardiac hypertrophy with enhanced ventricular function due to low systemic vascular resistance. This condition can progress to high-output heart failure, particularly in older individuals.
Area of Science:
- Cardiology
- Genetics
- Physiology
Background:
- Left ventricular hypertrophy (LVH) typically presents with reduced systolic/diastolic function, a risk factor for congestive heart failure.
- A less recognized phenotype of LVH involves enhanced ventricular function and increased cardiac output, potentially leading to high-output heart failure.
- This presentation can cause diagnostic and management challenges.
Purpose of the Study:
- To systematically characterize the cardiovascular phenotype of high-output cardiac hypertrophy in individuals with Cantu syndrome (CS).
- To investigate the long-term consequences of enhanced ventricular function and low systemic vascular resistance in CS patients.
Main Methods:
- Longitudinal study of 31 subjects with CS and confirmed ABCC9 variants.
- Assessment of cardiovascular phenotype, including left ventricular mass index and blood pressure, compared to controls.
- Evaluation of cardiac function and systemic vascular resistance.
Main Results:
- CS subjects exhibited significant left ventricular hypertrophy (LVMI 86.7 g/m² vs. 26.6 g/m² in controls) and low blood pressure (systolic 94.5 mmHg, diastolic 60 mmHg).
- Most CS subjects (21/31) showed eccentric hypertrophy with normal left ventricular wall thickness.
- Congestive heart failure symptoms were observed in 4 of 5 CS subjects over 40 years old.
Conclusions:
- The study defines the natural history of high-output cardiac hypertrophy in CS, driven by reduced systemic vascular resistance.
- Cantu syndrome serves as a key model for understanding the long-term effects of high-output hypertrophy.
- Progression to high-output heart failure is a potential outcome in individuals with CS.
Abstract:
Background Cardiomegaly caused by left ventricular hypertrophy is a risk factor for development of congestive heart failure, classically associated with decreased systolic and/or diastolic ventricular function. Less attention has been given to the phenotype of left ventricular hypertrophy with enhanced ventricular function and increased cardiac output, which is potentially associated with high-output heart failure. Lack of recognition may pose diagnostic ambiguity and management complexities. Methods and Results We sought to systematically characterize high-output cardiac hypertrophy in subjects with Cantu syndrome (CS), caused by gain-of-function variants in ABCC9, which encodes cardiovascular KATP (ATP-sensitive potassium) channel subunits. We studied the cardiovascular phenotype longitudinally in 31 subjects with CS with confirmed ABCC9 variants (median [interquartile range] age 8 years [3-32 years], body mass index 19.9 [16.5-22.9], 16 male subjects). Subjects with CS presented with significant left ventricular hypertrophy (left ventricular mass index 86.7 [57.7-103.0] g/m2 in CS, n=30; 26.6 [24.1-32.8] g/m2 in controls, n=17; P<0.0001) and low blood pressure (systolic 94.5 [90-103] mm Hg in CS, n=17; 109 [98-115] mm Hg in controls, n=17; P=0.0301; diastolic 60 [56-66] mm Hg in CS, n=17; 69 [65-72] mm Hg in control, n=17; P=0.0063). Most (21/31) subjects with CS exhibited eccentric hypertrophy with normal left ventricular wall thickness. Congestive heart failure symptoms were evident in 4 of the 5 subjects with CS aged >40 years on long-term follow-up. Conclusions The data define the natural history of high-output cardiac hypertrophy resulting from decreased systemic vascular resistance in subjects with CS, a defining population for long-term consequences of high-output hypertrophy caused by low systemic vascular resistance, and the potential for progression to high-output heart failure.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

